Summit Therapeutics
SMMT
#1676
Rank
NZ$22.04 B
Marketcap
NZ$28.40
Share price
-4.87%
Change (1 day)
-33.96%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: NZ$22.04 Billion

As of May 2026 Summit Therapeutics has a market cap of NZ$22.04 Billion. This makes Summit Therapeutics the world's 1676th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$22.04 B-5.45%
2025NZ$23.31 B-2.08%
2024NZ$23.81 B723.22%
2023NZ$2.89 B114.63%
2022NZ$1.34 B250.19%
2021NZ$0.38 B-28.18%
2020NZ$0.53 B235.74%
2019NZ$0.15 B465.79%
2018NZ$28.2 M-87.89%
2017NZ$0.23 B53.24%
2016NZ$0.15 B-26.22%
2015NZ$0.20 B

End of Day market cap according to different sources

On May 22nd, 2026 the market cap of Summit Therapeutics was reported to be:

NZ$22.04 Billion
by Nasdaq info icon info icon
NZ$22.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
NZ$3.03 B-86.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$0.38 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
NZ$0.42 B-98.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$10.53 B-52.21%๐Ÿ‡บ๐Ÿ‡ธ USA